bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.425
+0.035 (1.46%)
At close: Nov 11, 2026, 4:00 PM EST
2.450
+0.025 (1.03%)
After-hours: Nov 11, 2026, 5:15 PM EST
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $3.11 million as of November 11, 2026. It is the 46,643rd most valuable company in the world and the 6,176th biggest in the United States. Its market cap has decreased by 66.84% in one year.
Market Cap
3.11M
Enterprise Value
2.06M
1-Year Change
-66.84%
Global Rank
Country Rank
#6,176 United States
Category
ChartMarket Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $3.11M, a decrease of -93.09%. That is a compound annual growth rate of -47.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.11M | -41.31% |
| Dec 31, 2025 | 5.30M | -62.62% |
| Dec 31, 2024 | 14.18M | 1.49% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exagen | 159.16M |
| Burning Rock Biotech | 138.88M |
| Insight Molecular Diagnostics | 87.05M |
| Biodesix | 86.31M |
| Quantum Cyber | 61.92M |
| Precipio | 34.93M |
| MDxHealth | 15.50M |
| ENDRA Life Sciences | 7.06M |